Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200
2019
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200

Ranking timeline:

Project Participation Performance(2019-01-01 - 2021-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 50
As coordinator: 6
As participant: 38
Sole participant: 6
Coordinator / Participant Ratio: 0.16^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	9.146.198	23.710.231	7.418.176	5	9
2020	9.656.548	302.464.789	14.145.649	5	19
2019	3.484.844	158.798.802	5.621.172	2	10

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	10
KATHOLIEKE UNIVERSITEIT LEUVEN	9
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	8
UNIVERSITY OF CAMBRIDGE	8
CHARITE UNIVERSITAETSMEDIZIN BERLIN	7
EUROPEAN MOLECULAR BIOLOGY LABORATORY	7
PERCUROS BV	7
UNIVERSITY OF OSLO	7
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	6
STICHTING KATHOLIEKE UNIVERSITEIT	6
THE UNIVERSITY OF EDINBURGH	6
THE UNIVERSITY OF MANCHESTER	6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	5
COMMISSARIAT A L'ENERGIE ATOMIQUE	5
EATRIS ERIC	5
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	5
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG	5
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	5
KAROLINSKA INSTITUTE	5
KING'S COLLEGE LONDON	5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	5
UNIVERSITAETSKLINIKUM FREIBURG	5
UNIVERSITAT DE BARCELONA	5
UNIVERSITY COLLEGE LONDON	5
UNIVERSITY OF COPENHAGEN	5
ABBVIE INC	4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	4
CENTRE DE REGULACIO GENOMICA	4
EBERHARD KARLS UNIVERSITAET TUEBINGEN	4
HEINRICHHEINEUNIVERSITAET DUESSELDORF	4
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT	4
ISTITUTO SUPERIORE DI SANITA	4
JANSSEN PHARMACEUTICA NV	4
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW	4
MEDIZINISCHE UNIVERSITAT INNSBRUCK	4
PFIZER LIMITED	4
TECOBIOSCIENCES	4
UNIVERSITA DEGLI STUDI DI CAMERINO	4
UNIVERSITAETSKLINIKUM AACHEN	4
UNIVERSITE D'AIX MARSEILLE	4
UNIVERSITY OF DUNDEE	4
UNIVERSITY OF HELSINKI	4
UNIVERSITY OF NEWCASTLE UPON TYNE	4
UNIVERSITY OF WALES CARDIFF	4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	3
BAYER	3
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	3
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	3
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY	3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL	3
GOETEBORGS UNIVERSITET	3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	3
INSTITUT DE RECHERCHES SERVIER	3
INSTITUT PASTEUR	3
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES	3
KUNGLIGA TEKNISKA HOEGSKOLAN	3
MASARYKOVA UNIVERZITA	3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	3
MEDRES MEDICAL RESEARCH	3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	3
NATIONAL UNIVERSITY OF IRELAND GALWAY	3
NOVARTIS PHARMA	3
OSLO UNIVERSITETSSYKEHUS HF	3
REGION HOVEDSTADEN	3
SANOFIAVENTIS	3
SERVICIO MADRILENO DE SALUD	3
TAKEDA PHARMACEUTICALS INTERNATIONAL	3
TECHNISCHE UNIVERSITAET MUENCHEN	3
THE UNIVERSITY OF SHEFFIELD	3
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'	3
UNIVERSITAET BERN	3
UNIVERSITAET KARLSRUHE	3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	3
UNIVERSITE LIBRE DE BRUXELLES	3
UNIVERSITEIT ANTWERPEN	3
UNIVERSITEIT GENT	3
UNIVERSITEIT MAASTRICHT	3
UNIVERSITEIT UTRECHT	3
UNIVERSITY OF GLASGOW	3
UNIVERSITY OF LEEDS	3
ACADEMIC MEDICAL CENTRE AMSTERDAM	2
ACADEMISCH ZIEKENHUIS GRONINGEN	2
ASTRAZENECA	2
AZIENDA OSPEDALIERO UNIVERSITARIA PISANA	2
AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE	2
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION	2
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE	2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL	2
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES	2
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD	2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	2
CONCENTRIS RESEARCH MANAGEMENT	2
CONSIGLIO NAZIONALE DELLE RICERCHE	2
DANMARKS TEKNISKE UNIVERSITET	2
DRESDEN UNIVERSITY OF TECHNOLOGY	2
EIDGENOESSISCHES DEPARTEMENT DES INNERN	2

Constancy:

Total number of partners: 982
Partner loyalty:
Frequent Partner: (> 2 projects): 351
Rare Partner: 631
Frequent / Rare Partner Ratio: 0.56

Project overview:

Start date	Project	acronym	role	funding	partners
2021-04-01	Exploitation of a low-field scanner for physiotherapy and rheumatology	PR scanner	participant	100.000	2
2021-04-01	Coordinating Research and Evidence for Medical Devices	CORE-MD	participant	2.360.978	22
2021-03-01	HealthyCloud – Health Research & Innovation Cloud	HealthyCloud	participant	2.999.975	21
2021-03-01	NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242	A-TANGO	participant	5.999.999	14
2021-03-01	European Rare dIsease research Coordination and support Action	ERICA	coordinator	2.313.809	24
2021-03-01	Nanoparticle-Based Imaging and Therapy of Chronic Pain in the Dorsal Root Ganglia (DRG)	PIANO	participant	4.093.425	11
2021-03-01	APC/C substrates: how are they disengaged from their non-degraded binding partners?	UbiBranch	coordinator	187.572	1
2021-02-01	European consortium for communicating gene- and cell-based therapy information.	EuroGCT	participant	1.999.784	47
2021-02-01	The dark side of the genome: systematically studying the biology of repressive elements—silencers—in the human genome	Silencer	coordinator	1.750.000	1
2021-02-01	Embedding a comprehensive ethical dimension to organoïd-based research and resulting technologies	HYBRIDA	participant	2.995.785	8
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2021-01-01	Drug repurposing and discovery multidisciplinary training network	DRUGtrain	coordinator	2.394.817	8
2021-01-01	Viruses and Epitranscriptomics: seeking novel targets for antiviral therapy	EpiViral	participant	878.446	3
2021-01-01	Targeting auto-reactive B-cells by vaccination to cure human auto-immune disease	Target to B-cure	coordinator	2.500.000	1
2020-10-01	Immunological incompatibility as a basis for cancer curing and vaccination	ULISES	participant	2.977.160	10
2020-09-01	Biosafety assays for the diagnosis and prediction of drug-related complement pathology	Biosafety	participant	900.000	6
2020-09-01	Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM	RadoNorm	participant	18.000.000	56
2020-09-01	Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling	ACQUIRE	coordinator	150.000	1
2020-08-01	Indo-European Consortium for Next Generation Influenza Vaccine Innovation	INCENTIVE	participant	9.974.294	19
2020-06-01	DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE	TRANSVAC-DS	participant	1.879.216	25
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	22
2020-05-01	Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA	INNODIA HARVEST	participant	5.999.055	40
2020-05-01	Staff Exchange for Novel applications in 19f magnetic resonance imaging	SENATOR	participant	1.541.000	11
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	37
2020-04-01	Human Brain Project Specific Grant Agreement 3	HBP SGA3	participant	150.000.000	140
2020-04-01	Swift COronavirus therapeutics REsponse	SCORE	coordinator	2.576.063	8
2020-04-01	Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine	Prevent-nCoV	participant	2.728.340	7
2020-04-01	proactive monitoring of cancer as an alternative to surgery	PRISAR2	participant	2.484.000	25
2020-03-01	Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe	ISLET	participant	7.999.999	7
2020-03-01	Critical solutions for elderly well-being	RISE-WELL	coordinator	2.691.279	7
2020-02-01	Novel Applications in 19F Magnetic Resonance Imaging	NOVA-MRI	coordinator	4.051.634	12
2020-02-01	Selection of human iPSC-derived cardiomyocytes by sinGle cell geNe expression and pAtch clamp for a maTUre caRdiac modEl	SiGNATURE	coordinator	187.572	1
2020-01-01	Human Cell Atlas of the Pancreas	ESPACE	participant	4.962.495	10
2020-01-01	GROUP CARE FOR THE FIRST 1000 DAYS (GC_1000): If it takes a village to raise a child, group care is the first step	GC_1000	participant	3.999.998	10
2020-01-01	Brain Involvement iN Dystrophinopathies	BIND	participant	6.666.325	19
2020-01-01	A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.	SMA-TB	participant	6.388.104	9
2020-01-01	Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis	AutoCRAT	participant	7.452.770	9
2020-01-01	Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery	TrainCKDis	participant	4.017.848	11
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	47
2019-10-01	Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs)	SIMICA	participant	800.000	5
2019-06-01	Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa	VASA	participant	6.619.342	10
2019-05-01	Defining the antithrombin measurand: role of proteoforms in harmonisation of diagnostic tests in thrombosis	HarmonizATforms	coordinator	187.572	1
2019-03-01	Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis	ArthritisHeal	coordinator	3.297.271	17
2019-03-01	Providing an open collaborative space for digital biology in Europe	EOSC-Life	participant	26.145.996	47
2019-02-01	Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond	EU-OPENSCREEN-DRIVE	participant	4.999.564	34
2019-01-01	MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response	MICROB-PREDICT	participant	15.000.000	22
2019-01-01	European Joint Programme on Rare Diseases	EJP RD	participant	55.073.831	88
2019-01-01	Induced pluripotent stem cell-based therapy for spinal regeneration	iPSpine	participant	14.959.781	21
2019-01-01	Training network in drug discovery targeting TRIM Ubiquitin ligases in disease	TRIM-NET	participant	3.203.448	14

Alias institution names:

LEIDS UNIVERSITAIR MEDISCH CENTRUM

LEIDS UNIVERSITAIR MEDISCH CENTRUM - Netherlands